...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: What's the deal with Zenith?

RVXOT with all due respect, I see no sense in belabouring Don's latest Plan. I'll leave it at that.

I just don't buy it, period.

 

Koo

Share
New Message
Please login to post a reply